NextGen Bio

Found 6,130 articles

• nScrypt Launches First and Only Ruggedized Precision 3D Printer/Bioprinter

  10/15/2019

  Another rugged version of nScrypt's bioprinter was launched to the International Space Station in July 2019, for bioprinting human heart tissue in microgravity.

• RedHawk Holdings Launches New Corporate Website

  10/15/2019

  New Website Address is www.redhawkholdingscorp.com

• Tactical Medical Solutions Announces the Acquisition of Leading Medical Simulator Manufacturer, TraumaFX

  10/15/2019

  Tactical Medical Solutions, LLC (“TacMed”), a leading innovator and manufacturer of proprietary pre-hospital medical components and technology for tactical and civilian applications, and Guardian Capital Partners, announce the acquisition of TraumaFX Solutions, Inc. (“TFX”).

• MHK (Formerly MedHOK) Launches Next Version of CareProminence™ SaaS Platform

  10/15/2019

  MHK (formerly MedHOK), part of the Hearst Health network, announced today the launch of the next version of its CareProminence SaaS platform, introducing new features and functionality to help managed care organizations meet changing regulatory requirements, streamline operations, enhance user productivity, and improve member care.

• Parkinson's Foundation Launches National Program for People Newly Diagnosed with Parkinson's Disease

  10/15/2019

  The Parkinson's Foundation today announced the launch of Newly Diagnosed: Building a Better Life with Parkinson's Disease, a new campaign designed to arm people who are newly diagnosed with the knowledge, tools and resources they need to navigate life with Parkinson's disease (PD).

• Generex Biotechnology Announces Merger with Public Vehicle for Public Trading of NuGenerex Immuno-OncologyAcquisition to be finalized in October pending completion of legal documentation

  10/15/2019

  Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced a merger transaction with a public company that is DTC eligible and current with its SEC filings to serve as a vehicle for the quotation of the common stock of its subsidiary NuGenerex Immuno-Oncology (NGIO) as an independent, publicly traded company.

• U.S. FDA Approves SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophrenia

  10/15/2019

  A transdermal patch may help to mitigate some of the challenges patients face with the management of their schizophrenia.

• Christopher Lazzara joins Bravado Health's board of directors

  10/15/2019

  He is now a board member of the combined Clockspring-NRI corporation.

• New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia

  10/15/2019

  Vibativ® (telavancin) is a patented, FDA approved anti-infective for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia.

• Ashley Reynolds Named Chief Experience Officer for BioIQ

  10/15/2019

  BioIQ, a healthcare engagement and gap closure company that is redefining the way payers, employers and consumers navigate and connect with the U.S. healthcare system, has named Ashley L. Reynolds, PhD, RN, ACSM-HFS as its new chief experience officer.

• Survey Reveals Costly Disconnect Between Physicians and Hospitals About Retirement

  10/14/2019

  New Jackson Physician Search Study Shows Doctors Consider Less Notice on Retirement Necessary, Introducing Potential Repercussions for Hospital Finances

• A New Neuroscience-Based Wellness and Recovery Facility Is Opening in Palm Beach and It’s Like Nothing You’ve Ever Seen Before

  10/14/2019

   Inspire Palm Beach will officially open its doors this month on Oct.15, 2019, in West Palm Beach.

• Reminder: Generex Investor Conference Call Tomorrow October 15, 2019

  10/14/2019

  Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team tomorrow, October 15, 2019 at 9:30 AM Eastern time:

• Further restricting blood transfusions guidelines could save lives and money

  10/14/2019

  Blood transfusion guidelines may require further evaluation with an eye to reducing transfusions for patients with stable blood pressure, according to Divyajot Sadana, MD, from the Cleveland Clinic, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.

• Changing asthma inhaler devices abruptly may reduce lung function in children with asthma

  10/14/2019

  Children with asthma who are required to switch inhaler types to accommodate insurance formulary changes may experience a loss of lung function not seen in children whose inhaler type stayed the same, according to Scott Bickel, MD, from the University of Louisville School of Medicine, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.

• Pulmonary arterial hypertension treatment with macitentan is safe and effective for patients with systemic sclerosis

  10/14/2019

  Patients with pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc) who were treated with macitentan had similar therapeutic and safety results as patients with PAH from both idiopathic PAH (IPAH) and heritable PAH (HPAH), which is caused by a genetic mutation that runs in families, according to Vallerie McLaughlin, MD, FCCP, from the University of Michigan, Ann Arbor, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.

• Routine influenza vaccination for all adults hospitalized with pneumonia may save lives and reduce hospitalizations

  10/14/2019

  Among adults admitted to a hospital with pneumonia, patients who received an influenza vaccination had a lower chance of being readmitted, according to Kam Sing Ho, MD, from Mount Sinai St. Luke's and Mount Sinai West, New York City, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.

• Progressive Care Inc. Announces CEO, Shital Mars as Keynote Speaker at Cold Chain Global Forum in Boston, Massachusetts

  10/14/2019

  Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that CEO, Shital Mars will be the keynote speaker at Cold Chain Global Forum in Boston, Massachusetts on October 15-18, 2019.

• Combination drug therapy using macitentan and tadalafil for pulmonary arterial hypertension provides clear benefits

  10/14/2019

  Patients newly diagnosed with pulmonary arterial hypertension (PAH) treated with macitentan and tadalafil combination therapy showed hemodynamic progress, as well as improvements in function and risk profile, according to Olivier Sitbon, MD, PhD, from Université Paris–Sud, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.

• Identification of COPD, asthma and overlap syndrome can be teased out with spirometry following use of bronchodilator

  10/14/2019

  There is nearly a 40% chance of overdiagnosing chronic obstructive pulmonary disease (COPD) when spirometry is not combined with bronchodilator (BD) testing, often missing asthma and asthma-COPD overlap syndrome (ACOS), according to Srinadh Annangi, MD, from the University of Kentucky, School of Medicine, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans